¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå ±Ô¸ð, Á¡À¯À² ¹× µ¿Ç⠺м® º¸°í¼ : Àç·á À¯Çüº°, ¿ëµµº°, è¹ö À¯Çüº°, Å©±âº°, Ä¡·á ¿µ¿ªº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
Pharmaceutical Cartridges Market Size, Share & Trends Analysis Report By Material Type, By Application, By Chamber Type, By Size, By Therapeutic Area, By End-Use, By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå
:
1446551
¸®¼Ä¡»ç
:
Grand View Research, Inc.
¹ßÇàÀÏ
:
2024³â 02¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 300 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
ÀǾàǰ īƮ¸®Áö ½ÃÀå ¼ºÀå ¹× µ¿Çâ :
¼¼°è ÀǾàǰ īƮ¸®Áö ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 24¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 8.07%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Á¦¾à »ê¾÷ÀÇ ±Þ°ÝÇÑ ¼ºÀå, ÀÚ°¡ Åõ¾à ¾à¹° »ç¿ë Áõ°¡, ¿þ¾î·¯ºí ÀÎÁ§ÅÍ ¼ö¿ä Áõ°¡ µî ´Ù¾çÇÑ ¿äÀÎÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
¿þ¾î·¯ºí ÀÎÁ§ÅÍ´Â Àå½Ã°£¿¡ °ÉÃÄ ´Ù·®ÀÇ ¾à¹°À» Åõ¿©Çϱâ À§ÇØ ¼³°èµÇ¾úÀ¸¸ç, ¾à¹°ÀÇ ºÀÀÔ ¹× Åõ¿©¸¦ À§ÇØ ¹Ì¸® ä¿öÁø īƮ¸®Áö¸¦ »ç¿ëÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú È帧Àº ¿þ¾î·¯ºí ÀÎÁ§ÅÍ ½Ã½ºÅÛÀÇ °íÀ¯ÇÑ ¿ä±¸ »çÇ×À» ÃæÁ·Çϵµ·Ï Á¶Á¤µÈ ÀǾàǰ īƮ¸®ÁöÀÇ Çʿ伺À» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ä«Æ®¸®Áö´Â Á¤È®ÇÑ Åõ¾à Á¤È®µµ¸¦ Á¦°øÇϰí, ´Ù¾çÇÑ ¾à¹°°úÀÇ È£È¯¼ºÀ» º¸ÀåÇϸç, ¿À·£ ½Ã°£ µ¿¾È ¾à¹°ÀÇ ¾ÈÁ¤¼ºÀ» À¯ÁöÇÕ´Ï´Ù. Á¦¾àȸ»ç¿Í Á¦Á¶¾÷üµéÀº ¿þ¾î·¯ºí ÀÎÁ§ÅÍ¿¡ ÀûÇÕÇÑ ÀǾàǰÀ» °³¹ßÇÏ´Â °ÍÀ» ¿ì¼±¼øÀ§·Î »ï°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼¿¡ µû¶ó ÀÌ·¯ÇÑ Ã·´Ü ¾à¹° Àü´Þ ½Ã½ºÅÛÀÇ Æ¯Â¡ÀûÀÎ »ç¾ç¿¡ ¸Â´Â Àü¿ë īƮ¸®Áö¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
¿¹¸¦ µé¾î, 2023³â 10¿ù Enable Injections´Â Çõ½ÅÀûÀÎ ¿þ¾î·¯ºí ÀÎÁ§ÅÍ Empaveli InjectorÀÇ FDA ½ÂÀÎÀ» ¹Þ¾Ò´Ù°í ¹àÇû½À´Ï´Ù. ÀÌ Ã·´Ü ¿þ¾î·¯ºí ±â±â´Â ¹ßÀÛ¼º ¾ß°£ Ç÷»ö¼Ò´¢ÁõÀ» ¾Î°í ÀÖ´Â ¼ºÀΠȯÀÚµéÀ» À§ÇØ Æ¯º°È÷ °í¾ÈµÈ Á¦Ç°ÀÔ´Ï´Ù. ÇÚÁîÇÁ¸®·Î ¾à¹°À» Àü´ÞÇÒ ¼ö ÀÖÀ¸¸ç, ÃÖ´ë 25ml±îÁö ÁÖÀÔÇÒ ¼ö ÀÖ½À´Ï´Ù. ´ÙÀç´Ù´ÉÇÑ µðÀÚÀÎÀ¸·Î °¡Á¤À̳ª ÀÓ»ó ÇöÀå¿¡¼ ½±°Ô »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. À̹ø ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀº ÀÌ ÀåÄ¡ÀÇ È¿°ú¿Í ¾ÈÀü¼ºÀ» °Á¶ÇÏ´Â °ÍÀ¸·Î, ¹ßÀÛ¼º ¾ß°£ Ç÷»ö¼Ò´¢ÁõÀ¸·Î °íÅë¹Þ´Â ȯÀڵ鿡°Ô º¸´Ù °£ÆíÇϰí È¿°úÀûÀÎ Ä¡·á ÁßÀ縦 Á¦°øÇÔÀ¸·Î½á Å« µµ¿òÀÌ µÉ °ÍÀ¸·Î ±â´ëµË´Ï´Ù. ȯÀÚ Áß½ÉÀÇ ¾à¹° Àü´Þ ¼Ö·ç¼Ç, ±â¼ú ¹ßÀü, ¿þ¾î·¯ºí ÀÎÁ§ÅÍÀÇ º¸±Þ È®´ë°¡ ±³Â÷ÇÏ¸é¼ Á¦¾à¾÷°èÀÇ »óȲÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù.
Á¦¾àȸ»ç¿Í īƮ¸®Áö Á¦Á¶¾÷üµéÀÌ º¯ÈÇÏ´Â ÀÇ·á ¼ºñ½º ¼ö¿ä¿¡ ÀûÀÀÇϱâ À§ÇØ Àü·«À» ÀçÆíÇÔ¿¡ µû¶ó ÀÌ ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖÀ¸¸ç, ¿ªµ¿ÀûÀ̰í Çõ½ÅÀûÀÎ ÀÌ ºÐ¾ß¿¡¼ Çõ½Å°ú Çù¾÷¿¡ ´ëÇÑ Ç³ºÎÇÑ Àü¸ÁÀ» Á¦½ÃÇÒ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, µðÁöÅÐ Çコ ±â¼ú°ú ¿þ¾î·¯ºí ÀÎÁ§ÅÍÀÇ À¶ÇÕÀº ¸ð´ÏÅ͸µ, ¼øÀÀµµ ¹× Àü¹ÝÀûÀΠȯÀÚ °á°ú¸¦ Çâ»ó½ÃŰ´Â ÀüÀÚ ½Ã½ºÅÛ°ú ÅëÇÕ °¡´ÉÇÑ ½º¸¶Æ® īƮ¸®Áö¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½ÃÄÑ »ê¾÷ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
ÀǾàǰ īƮ¸®Áö ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
ÇÃ¶ó½ºÆ½ īƮ¸®Áö ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR 8.93%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇÃ¶ó½ºÆ½Àº ±Ý¼Ó ¹× À¯¸®¿Í ºñ±³ÇÏ¿© °æ·®, °¡´Ü¼º, ºñ¿ë È¿À²¼º°ú °°Àº À¯¸®ÇÑ Æ¯¼ºÀ¸·Î ÀÎÇØ Æ÷Àå ¼Ö·ç¼Ç¿¡ ¼±È£µÇ°í ÀÖ½À´Ï´Ù.
¿þ¾î·¯ºí ÀÎÁ§ÅÍ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR 9.33%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À̴ ȨÄɾ ´ëÇÑ ¼±È£µµ Áõ°¡¿Í ¾à¹° Àü´Þ ±â¼úÀÇ ¹ßÀü¿¡ ±âÀÎÇÕ´Ï´Ù.
µà¾ó è¹ö ºÎ¹®Àº ¹Î°¨ÇÑ »ý¹°ÇÐÀû Á¦Á¦ ¹× º¹ÀâÇÑ ¾à¹° Á¦Á¦ÀÇ º¸Á¸ ±â°£°ú È¿´ÉÀ» Çâ»ó½Ãų ¼ö Àֱ⠶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR 8.61%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
3ml ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR 9.26%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¦¾àȸ»çµéÀº °³º° ȯÀÚÀÇ ¿ä±¸¿¡ ¸Â´Â ¾à¹°À» °³¹ßÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸¸ç, 3ml īƮ¸®Áö Å©±â´Â ´Ù¾çÇÑ ¿ë·® ¿ä±¸ »çÇ×À» ÃæÁ·ÇÒ ¼ö ÀÖ´Â ¹ü¿ëÀûÀÎ ¼±ÅñÇÀ» Á¦°øÇÕ´Ï´Ù.
´ç´¢º´ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR 9.69%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´ç´¢º´ À¯º´·ü Áõ°¡¿Í ³ë·É Àα¸ Áõ°¡°¡ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
±âŸ ÃÖÁ¾»ç¿ëÀÚ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR 9.61%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÃÖÁ¾ »ç¿ëÀÚ ºÐ¾ß¿¡´Â »ý¸í°úÇÐ ±â¾÷, Çмú ±â°ü, Á¦¾à/ÃæÁø ¹× ¸¶°¨ ¼öŹ Á¦Á¶¾÷ü°¡ Æ÷ÇԵ˴ϴÙ.
ºÏ¹Ì´Â ÀÌ Áö¿ª¿¡¼ īƮ¸®Áö¸¦ Á¦Á¶ÇÏ´Â Á¦¾àȸ»ç°¡ ¸¹±â ¶§¹®¿¡ 2023³â ÀǾàǰ īƮ¸®Áö ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ÀǾàǰ īƮ¸®Áö ½ÃÀå : º¯¼ö, µ¿Çâ ¹× ¹üÀ§
½ÃÀå °èÅë Àü¸Á
½ÃÀå ¿ªÇÐ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
½ÃÀå ±âȸ ºÐ¼®
½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦ ºÐ¼®
ÀǾàǰ īƮ¸®Áö ½ÃÀå ºÐ¼® Åø
¾÷°è ºÐ¼® - PorterÀÇ Five Forces ºÐ¼®
PESTEL ºÐ¼®
Á¦4Àå ÀǾàǰ īƮ¸®Áö ½ÃÀå : Àç·á À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®
ºÎ¹® ´ë½Ãº¸µå
¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå º¯µ¿ ºÐ¼®
¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, Àç·á À¯Çüº°, 2018-2030³â
À¯¸® īƮ¸®Áö
ÇÃ¶ó½ºÆ½ īƮ¸®Áö
°í¹«
Á¦5Àå ÀǾàǰ īƮ¸®Áö ½ÃÀå : ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®
ºÎ¹® ´ë½Ãº¸µå
¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå º¯µ¿ ºÐ¼®
¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, ¿ëµµº°, 2018-2030³â
Ä¡°ú ¸¶Ãë
Ææ ÀÎÁ§ÅÍ
ÀÚ°¡ÁÖ»ç±â
¿þ¾î·¯ºí ÀÎÁ§ÅÍ
Á¦6Àå ÀǾàǰ īƮ¸®Áö ½ÃÀå : è¹ö À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®
ºÎ¹® ´ë½Ãº¸µå
¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå º¯µ¿ ºÐ¼®
¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, è¹ö À¯Çüº°, 2018-2030³â
µà¾ó è¹ö
´ë¿ë·®
Á¦7Àå ÀǾàǰ īƮ¸®Áö ½ÃÀå : »çÀÌÁî ÃßÁ¤¡¤µ¿Ç⠺м®
ºÎ¹® ´ë½Ãº¸µå
¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå º¯µ¿ ºÐ¼®
¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, »çÀÌÁ, 2018-2030³â
0.5ml
1.8ml
2 ml-2.5ml
3ml
5ml
10ml ÀÌ»ó
Á¦8Àå ÀǾàǰ īƮ¸®Áö ½ÃÀå : Ä¡·á ¿µ¿ª ÃßÁ¤¡¤µ¿Ç⠺м®
ºÎ¹® ´ë½Ãº¸µå
¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå º¯µ¿ ºÐ¼®
¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, Ä¡·á ¿µ¿ªº°, 2018-2030³â
¾È°ú
È£Èí±â
½Å°æ
Á¾¾ç
¸é¿ª
½ÉÀ庴
´ç´¢º´
Ä¡°ú
±âŸ
Á¦9Àå ÀǾàǰ īƮ¸®Áö ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®
ºÎ¹® ´ë½Ãº¸µå
¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå º¯µ¿ ºÐ¼®
¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, ÃÖÁ¾ ¿ëµµº°, 2018-2030³â
ÀǾàǰ
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö
¿¬±¸±â°ü
±âŸ
Á¦10Àå ÀǾàǰ īƮ¸®Áö ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®, Àç·á À¯Çüº°, ¿ëµµº°, è¹ö À¯Çüº°, »çÀÌÁ, Ä¡·á ¿µ¿ªº°, ÃÖÁ¾ ¿ëµµº°
Áö¿ª ´ë½Ãº¸µå
2018³âºÎÅÍ 2030³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
ºÏ¹Ì
À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
¶óƾ¾Æ¸Þ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦11Àå °æÀï ±¸µµ
½ÃÀå ÁøÃâ±â¾÷ ºÐ·ù
ÁÖ¿ä ±â¾÷ °³¿ä
Stevanato Group
NIPRO
Gerresheimer AG
West Pharmaceutical Services, Inc.
Schott AG
Transcoject GmbH
Shandong Medicinal Glass Co., Ltd.
Datwyler Holding Inc.
AptarGroup, Inc.
Sonata Rubber
È÷Æ®¸Ê ºÐ¼®/±â¾÷ ½ÃÀå ÇöȲ ºÐ¼®
ÃßÁ¤ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
±âŸ ÁÖ¿ä ½ÃÀå ±â¾÷ ¸®½ºÆ®
LSH
¿µ¹® ¸ñÂ÷
Pharmaceutical Cartridges Market Growth & Trends:
The global pharmaceutical cartridges market size is anticipated to reach USD 2.43 billion by 2030 and is anticipated to expand at a CAGR of 8.07% from 2024 to 2030. The market is driven by various factors such as rapid growth in the pharmaceutical industry, increasing use of self-administered medications, and rising demand for wearable injectors.
Wearable injectors are designed for dispensing substantial drug volumes over prolonged periods and frequently employ pre-filled cartridges for containment and administration of medications. This trajectory in technology amplifies the need for pharmaceutical cartridges tailored to meet the distinctive demands of wearable injector systems. Such cartridges provide exact dosing precision, assure compatibility with diverse drugs, and sustain the stability of medications throughout extended durations. Pharmaceutical companies and manufacturers are progressively prioritizing the development of pharmaceuticals compatible with wearable injectors. This trend has led to heightened demand for specialized cartridges tailored to meet the distinctive specifications of these advanced drug delivery systems.
For instance, in October 2023, Enable Injections revealed the FDA approval for its innovative wearable injector, Empaveli Injector. This advanced wearable device is specifically designed for the adult demographic with paroxysmal nocturnal hemoglobinuria. It offers a hands-free drug delivery mechanism, accommodating a volume of up to 25 ml. Its versatile design facilitates utilization both within the confines of one's home and in clinical settings. This regulatory endorsement underscores the device's efficacy and safety, significantly empowering individuals grappling with paroxysmal nocturnal hemoglobinuria through enhanced and convenient therapeutic interventions. The intersection of patient-centric drug delivery solutions, technological advancements, and the rising prevalence of wearable injectors is molding the landscape of pharmaceutical industry.
As pharmaceutical companies and cartridge manufacturers realign their strategies to adapt to changing demands of healthcare delivery, the market is set for sustained growth, presenting abundant prospects for innovation and collaboration in this dynamic and transformative sector. Additionally, the convergence of digital health technologies with wearable injectors is further amplifying the demand for smart cartridges capable of integrating with electronic systems to enhance monitoring, adherence, and overall patient outcomes thus propelling the industry growth.
Pharmaceutical Cartridges Market Report Highlights:
Plastic cartridges segment is expected to register the fastest CAGR of 8.93% during the forecast period. Plastic is preferred for packaging solutions due to its favorable characteristics, including low weight, malleability, and cost-effectiveness, in comparison to metal and glass
Wearable injectors segment is expected to register the fastest CAGR of 9.33% during the forecast period. This is due to the growing preference for homecare settings and advancements in drug delivery technologies
Dual chamber segment is expected to register the fastest CAGR of 8.61% during the forecast period owing its ability to enhance the shelf life and efficacy of sensitive biologics and complex drug formulations
3ml segment is expected to register the fastest CAGR of 9.26% during the forecast period. Pharmaceutical companies are increasingly developing drugs tailored to individual patient needs, and 3ml cartridge size provides a versatile option for accommodating varying dosage requirements
Diabetes segment is expected to register the fastest CAGR of 9.69% during the forecast period. Increasing incidence of diabetes coupled with rising geriatric population drive the segment growth
Others end-use segment is expected to register the fastest CAGR of 9.61% during the forecast period. Other end-users segment includes life sciences companies, academic institutes, and drug product/ fill & finish contract manufacturers
North America dominated the pharmaceutical cartridges market in 2023 owing to the presence of majority of pharmaceutical companies manufacturing cartridges in this region
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Pharmaceutical Cartridges Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rapid Growth In The Global Pharmaceutical Industry
3.2.1.2. Growing Demand For Drug Delivery Devices
3.2.2. Market Restraint Analysis
3.2.2.1. Challenges Associated With Glass Surface
3.2.3. Market Opportunities Analysis
3.2.3.1. Rising Preference For Injectable Drug Formulations
3.2.4. Market Challenge Analysis
3.2.4.1. Stringent Regulatory Framework
3.3. Pharmaceutical Cartridges Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
Chapter 4. Pharmaceutical Cartridges Market: Material Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Pharmaceutical Cartridges Market Movement Analysis
4.3. Global Pharmaceutical Cartridges Market Size & Trend Analysis, by Material Type, 2018 to 2030 (USD Million)
4.4. Glass Cartridges
4.4.1. Glass Cartridges Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Type 1
4.4.2.1. Type 1 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Type 2
4.4.3.1. Type 2 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Type 3
4.4.4.1. Type 3 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Plastic Cartridges
4.5.1. Plastic Cartridges Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Polypropylene (PP)
4.5.2.1. Polypropylene (PP) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Cyclic Olefin Copolymer (COC)
4.5.3.1. Cyclic Olefin Copolymer (COC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Cyclic Olefin Polymer (COP)
4.5.4.1. Cyclic Olefin Polymer (COP) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.5. Polyethylene
4.5.5.1. Polyethylene Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Rubber
4.6.1. Rubber Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Pharmaceutical Cartridges Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Pharmaceutical Cartridges Market Movement Analysis
5.3. Global Pharmaceutical Cartridges Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Dental Anesthesia
5.4.1. Dental Anesthesia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Pen Injectors
5.5.1. Pen Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Autoinjectors
5.6.1. Autoinjectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Wearable Injectors
5.7.1. Wearable Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Pharmaceutical Cartridges Market: Chamber Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Pharmaceutical Cartridges Market Movement Analysis
6.3. Global Pharmaceutical Cartridges Market Size & Trend Analysis, by Chamber Type, 2018 to 2030 (USD Million)
6.4. Dual Chamber
6.4.1. Dual Chamber Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Large Volume
6.5.1. Large Volume Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Pharmaceutical Cartridges Market: Size Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Pharmaceutical Cartridges Market Movement Analysis
7.3. Global Pharmaceutical Cartridges Market Size & Trend Analysis, by Size, 2018 to 2030 (USD Million)
7.4. 0.5 ml
7.4.1. 0.5ml Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. 1.8 ml
7.5.1. 1.8ml Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. 2ml to 2.5 ml
7.6.1. 2ml to 2.5 ml Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. 3 ml
7.7.1. 3ml Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. 5 ml
7.8.1. 5ml Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9. More than 10 ml
7.9.1. More than 10 ml Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Pharmaceutical Cartridges Market: Therapeutic Area Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global Pharmaceutical Cartridges Market Movement Analysis
8.3. Global Pharmaceutical Cartridges Market Size & Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
8.4. Ophthalmology
8.4.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Respiratory
8.5.1. Respiratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Neurology
8.6.1. Neurology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Oncology
8.7.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8. Immunology
8.8.1. Immunology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.9. Cardiology
8.9.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.10. Diabetes
8.10.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.11. Dental
8.11.1. Dental Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.12. Others
8.12.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Pharmaceutical Cartridges Market: End Use Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. Global Pharmaceutical Cartridges Market Movement Analysis
9.3. Global Pharmaceutical Cartridges Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
9.4. Pharmaceutical
9.4.1. Pharmaceutical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Biotechnology
9.5.1. Biotechnology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Research Organizations
9.6.1. Research Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
9.7. Others
9.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Pharmaceutical Cartridges Market: Regional Estimates & Trend Analysis By Material Type, By Application, By Chamber Type, By Size, By Therapeutic Area, By End-use
10.1. Regional Dashboard
10.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
10.3. North America
10.3.1. North America Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.3.2. U.S.
10.3.2.1. Key Country Dynamics
10.3.2.2. Competitive Scenario
10.3.2.3. Regulatory Scenario
10.3.2.4. Reimbursement Scenario
10.3.2.5. U.S. Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.3.3. Canada
10.3.3.1. Key Country Dynamics
10.3.3.2. Competitive Scenario
10.3.3.3. Regulatory Scenario
10.3.3.4. Reimbursement Scenario
10.3.3.5. Canada Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4. Europe
10.4.1. Europe Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4.2. UK
10.4.2.1. Key Country Dynamics
10.4.2.2. Competitive Scenario
10.4.2.3. Regulatory Scenario
10.4.2.4. Reimbursement Scenario
10.4.2.5. UK Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4.3. Germany
10.4.3.1. Key Country Dynamics
10.4.3.2. Competitive Scenario
10.4.3.3. Regulatory Scenario
10.4.3.4. Reimbursement Scenario
10.4.3.5. Germany Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4.4. France
10.4.4.1. Key Country Dynamics
10.4.4.2. Competitive Scenario
10.4.4.3. Regulatory Scenario
10.4.4.4. Reimbursement Scenario
10.4.4.5. France Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4.5. Italy
10.4.5.1. Key Country Dynamics
10.4.5.2. Competitive Scenario
10.4.5.3. Regulatory Scenario
10.4.5.4. Reimbursement Scenario
10.4.5.5. Italy Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4.6. Spain
10.4.6.1. Key Country Dynamics
10.4.6.2. Competitive Scenario
10.4.6.3. Regulatory Scenario
10.4.6.4. Reimbursement Scenario
10.4.6.5. Spain Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4.7. Denmark
10.4.7.1. Key Country Dynamics
10.4.7.2. Competitive Scenario
10.4.7.3. Regulatory Scenario
10.4.7.4. Reimbursement Scenario
10.4.7.5. Denmark Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4.8. Sweden
10.4.8.1. Key Country Dynamics
10.4.8.2. Competitive Scenario
10.4.8.3. Regulatory Scenario
10.4.8.4. Reimbursement Scenario
10.4.8.5. Sweden Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4.9. Norway
10.4.9.1. Key Country Dynamics
10.4.9.2. Competitive Scenario
10.4.9.3. Regulatory Scenario
10.4.9.4. Reimbursement Scenario
10.4.9.5. Norway Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.5. Asia Pacific
10.5.1. Asia Pacific Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.5.2. Japan
10.5.2.1. Key Country Dynamics
10.5.2.2. Competitive Scenario
10.5.2.3. Regulatory Scenario
10.5.2.4. Reimbursement Scenario
10.5.2.5. Japan Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.5.3. China
10.5.3.1. Key Country Dynamics
10.5.3.2. Competitive Scenario
10.5.3.3. Regulatory Scenario
10.5.3.4. Reimbursement Scenario
10.5.3.5. China Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.5.4. India
10.5.4.1. Key Country Dynamics
10.5.4.2. Competitive Scenario
10.5.4.3. Regulatory Scenario
10.5.4.4. Reimbursement Scenario
10.5.4.5. India Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.5.5. South Korea
10.5.5.1. Key Country Dynamics
10.5.5.2. Competitive Scenario
10.5.5.3. Regulatory Scenario
10.5.5.4. Reimbursement Scenario
10.5.5.5. South Korea Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.5.6. Australia
10.5.6.1. Key Country Dynamics
10.5.6.2. Competitive Scenario
10.5.6.3. Regulatory Scenario
10.5.6.4. Reimbursement Scenario
10.5.6.5. Australia Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.5.7. Thailand
10.5.7.1. Key Country Dynamics
10.5.7.2. Competitive Scenario
10.5.7.3. Regulatory Scenario
10.5.7.4. Reimbursement Scenario
10.5.7.5. Thailand Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.6. Latin America
10.6.1. Latin America Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.6.2. Brazil
10.6.2.1. Key Country Dynamics
10.6.2.2. Competitive Scenario
10.6.2.3. Regulatory Scenario
10.6.2.4. Reimbursement Scenario
10.6.2.5. Brazil Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.6.3. Mexico
10.6.3.1. Key Country Dynamics
10.6.3.2. Competitive Scenario
10.6.3.3. Regulatory Scenario
10.6.3.4. Reimbursement Scenario
10.6.3.5. Mexico Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.6.4. Argentina
10.6.4.1. Key Country Dynamics
10.6.4.2. Competitive Scenario
10.6.4.3. Regulatory Scenario
10.6.4.4. Reimbursement Scenario
10.6.4.5. Argentina Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.7. Middle East & Africa
10.7.1. Middle East & Africa Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.7.2. South Africa
10.7.2.1. Key Country Dynamics
10.7.2.2. Competitive Scenario
10.7.2.3. Regulatory Scenario
10.7.2.4. Reimbursement Scenario
10.7.2.5. South Africa Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.7.3. Saudi Arabia
10.7.3.1. Key Country Dynamics
10.7.3.2. Competitive Scenario
10.7.3.3. Regulatory Scenario
10.7.3.4. Reimbursement Scenario
10.7.3.5. Saudi Arabia Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.7.4. UAE
10.7.4.1. Key Country Dynamics
10.7.4.2. Competitive Scenario
10.7.4.3. Regulatory Scenario
10.7.4.4. Reimbursement Scenario
10.7.4.5. UAE Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.7.5. Kuwait
10.7.5.1. Key Country Dynamics
10.7.5.2. Competitive Scenario
10.7.5.3. Regulatory Scenario
10.7.5.4. Reimbursement Scenario
10.7.5.5. Kuwait Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 11. Competitive Landscape
11.1. Market Participant Categorization
11.2. Key Company Profiles
11.2.1. Stevanato Group
11.2.1.1. Company Overview
11.2.1.2. Financial Performance
11.2.1.3. Service Benchmarking
11.2.1.4. Strategic Initiatives
11.2.2. NIPRO
11.2.2.1. Company Overview
11.2.2.2. Financial Performance
11.2.2.3. Service Benchmarking
11.2.2.4. Strategic Initiatives
11.2.3. Gerresheimer AG
11.2.3.1. Company Overview
11.2.3.2. Financial Performance
11.2.3.3. Service Benchmarking
11.2.3.4. Strategic Initiatives
11.2.4. West Pharmaceutical Services, Inc.
11.2.4.1. Company Overview
11.2.4.2. Financial Performance
11.2.4.3. Service Benchmarking
11.2.4.4. Strategic Initiatives
11.2.5. Schott AG
11.2.5.1. Company Overview
11.2.5.2. Financial Performance
11.2.5.3. Service Benchmarking
11.2.5.4. Strategic Initiatives
11.2.6. Transcoject GmbH
11.2.6.1. Company Overview
11.2.6.2. Financial Performance
11.2.6.3. Service Benchmarking
11.2.6.4. Strategic Initiatives
11.2.7. Shandong Medicinal Glass Co., Ltd.
11.2.7.1. Company Overview
11.2.7.2. Financial Performance
11.2.7.3. Service Benchmarking
11.2.7.4. Strategic Initiatives
11.2.8. Datwyler Holding Inc.
11.2.8.1. Company Overview
11.2.8.2. Financial Performance
11.2.8.3. Service Benchmarking
11.2.8.4. Strategic Initiatives
11.2.9. AptarGroup, Inc.
11.2.9.1. Company Overview
11.2.9.2. Financial Performance
11.2.9.3. Service Benchmarking
11.2.9.4. Strategic Initiatives
11.2.10. Sonata Rubber
11.2.10.1. Company Overview
11.2.10.2. Financial Performance
11.2.10.3. Service Benchmarking
11.2.10.4. Strategic Initiatives
11.3. Heat Map Analysis/ Company Market Position Analysis
11.4. Estimated Company Market Share Analysis, 2023
11.5. List of Other Key Market Players
°ü·ÃÀÚ·á